Driven by the development of new generation, low dose, lower side effects, hormonal contraceptives, the world contraceptives market is projected to reach US$11.7 billion by the year 2010. Strong growth is expected to stem from developing countries where growing population, and rising incidences of STDs, and AIDS are causes of national concern. The significant role played by governments in these countries in the form of establishing, and implementing social marketing programs is poised to benefit sales of contraceptives in the upcoming years.

San Jose, California (PRWEB) March 17, 2008 -- World Contraceptives Market stands enthused by the huge untapped potential in developing countries like China, and India. An estimated 50% of condoms sold are branded and available commercially while the remaining is distributed in developing countries under social marketing programs designed to promote safe sex. The growing cultural trend of postponing childbearing until later in life, is offering opportunities for the market's growth in both developed and developing countries alike. In the recent times, planned parenthood is rising in popularity as well informed, educated couples make premeditated decisions on parenting a child or children. The reason fingered for postponing pregnancies to later in life, is the rising level of education, sophistication, and consequently career goals among young workingwomen. The desire to be financially independent, and stable has redefined the priorities of an average woman.

While the developed countries with their rapidly growing base of aging population face unfavorable demographics such as, decline in the number of females in the child bearing age, and falling fertility rates, the developing countries are expected to offer the required impetus for future growth. As stated by the recent report published by Global Industry Analysts, Inc., world market for contraceptive Implants/Injections is forecast to grow the strongest in Asia-Pacific over the period 2000 to 2015, to reach US$359.60 million by the year 2015. World oral contraceptives market is dominated by the United States and Europe with a combined 75.82% share estimated in the year 2007. By the year 2015, sales of condoms in Latin America are forecasted to reach US$841.5 million.

Leading global and regional players operating in the industry include Ansell Limited, Barr Pharmaceuticals Inc., Bayer Schering Pharma AG, Female Health Company, Church & Dwight Co. Inc., Conceptus Inc, Condomi Health International, Ortho-McNeil Pharmaceutical Inc, Schering-Plough Corporation, Organon USA Inc, SSL International PLC, Wyeth Corporation, and Warner Chilcott, among others.

The report titled "Contraceptives: A Global Strategic Business Report" published by Global Industry Analysts, Inc., provides a comprehensive review of market trends, drivers, issues, and challenges. Richly annotated with authoritative, and unbiased commentaries, and hard-to-find statistical facts, the report provides unequivocal views on future potential while throwing light on the prevailing climate in key regional markets. Latent demand patterns for contraceptives are quantified across major geographic market verticals including the United States, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia) Asia-Pacific, and Latin America. Product markets analyzed in the report include Oral Contraceptives, Condoms, and Implants/Injections. Also provided in the report is an enumeration of recent mergers, acquisitions, and other strategic industry activities.

For more details about this research report, please visit
http://www.strategyr.com/Contraceptives_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs more than 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of more than 60,000 smaller research products including company reports, market trend reports and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press@StrategyR.com
Web Site www.StrategyR.com

###

Simillar Articles

Veterinary Vaccines Market to Reach $4.5 Billion by 2010, According to New Report by Global...

Veterinary Vaccines, a critical segment of the animal healthcare industry, is largely driven by technological advancements coupled with development of new vaccines. World market for Veterinary...

$100 Billion of US and European Pharmaceutical Company Revenues Threatened by Generic Drugs...

Generics grow to capture 14% of the global healthcare market.

Global Medicated Skin Care Products Market to Reach $6.1 Billion by 2012, According to New Report...

With focus pitched on maintaining the healthy and youthful appearance of skin, rising impetus on preventive skin care is surging among the young and old alike. Driven by favorable trends, the...

Birth Control Patch Side Effects Lawsuit Filed by Hissey Kientz, LLP

Hissey Kientz, LLP has filed a lawsuit on behalf of a 30-year-old woman who suffered a blood clot in her leg after using the Ortho Evra birth control patch.

Monoclonal Antibody-Based Products Market to Reach $68.4 Billion by 2015, According to New Report...

Monoclonal antibodies represent one of the successes of the biotechnology industry along with a broad range of therapeutics and diagnostics. By the year 2015, monoclonal antibody-based products...

Home